Skip to content
S7527Senate2023-2024 SessionSame asA7724

Expand Lab License Scope

Official title

“Relates to restricted clinical laboratory licenses”

Sponsor Iwen ChuSD-17Affects Education
Status
Signed by Governor
Impact
5/10
Moderate
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill updates the education law to expand restricted clinical laboratory licenses to include molecular testing and toxicology.

Why it matters

  1. Expanding restricted clinical laboratory licenses to include "molecular testing" (not just molecular diagnosis) broadens what licensed technologists are legally allowed to do. This reflects rapid advances in genetic, infectious disease, and cancer diagnostics, and could help labs keep pace with evolving medical standards and technology.

  2. Allowing toxicology as a certified area under restricted licenses addresses workforce shortages and the growing need for specialized testing, especially related to substance use, pain management, and public health monitoring. This could make it easier for labs to hire qualified personnel and improve access to timely toxicology results.

  3. The changes may help major hospitals and cancer centers more efficiently fill staffing gaps and offer advanced laboratory services, especially in high-demand fields like molecular oncology and mass spectrometry. This could accelerate patient access to cutting-edge diagnostic tests and potentially improve outcomes for complex or rare diseases.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Restricted clinical laboratory licensees

    The bill would broaden the molecular work eligible for their certificates from molecular diagnosis limited to genetic testing-molecular and molecular oncology to molecular testing.

  • Clinical laboratories

    The bill would expand the molecular testing scope available under restricted licenses for staff performing examinations and procedures listed on their certificates.

  • National Cancer Institute-designated cancer centers and eligible teaching hospitals

    The bill would update their employees’ restricted-license certificate provisions to refer to molecular testing rather than molecular diagnosis.

  • New York State Education Department

    The bill would change the scope of molecular work for which the department may issue restricted clinical laboratory licenses and certificates.

Headline styles

Expand Lab License Scope

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Iwen Chu

Senator · Senate District 17

Chair, Libraries

No co-sponsors yet.

History

  1. Signed chap.186
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.896
  6. Substituted for A7724
  7. Referred to higher education
  8. Delivered to assembly
  9. Passed senateVote 62–0
  10. Ordered to third reading cal.1784
  11. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7724Assembly

Expand Lab License Scope

Assembly Floor Calendar · Sponsor Sarah Clark

Impact 5 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7527

2023-2024 Regular Sessions

IN SENATE

June 2, 2023

Introduced by Sen. CHU -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the education law, in relation to restricted clinical laboratory licenses

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraphs (a) and (b) of subdivision 1 of section 8610 of the education law, as amended by chapter 227 of the laws of 2019, are amended to read as follows:

(a) The department may issue a restricted license pursuant to which the restricted licensee may receive a certificate to perform certain examinations and procedures within the definition of clinical laboratory technology set forth in subdivision one of section eighty-six hundred one of this article, provided that such a restricted licensee may perform examinations and procedures only in those of the following areas which are specifically listed in his or her certificate: histocompatibility, cytogenetics, stem cell process, flow cytometry/cellular immunology [and molecular diagnosis to the extent such molecular diagnosis is included in genetic testing-molecular and molecular oncology], molecular testing, and toxicology (under paragraph (b-1) of this subdivision).

(b) Notwithstanding paragraph (a) of this subdivision, restricted licensees employed at National Cancer Institute designated cancer centers or at teaching hospitals that are eligible for distributions pursuant to paragraph (c) of subdivision three of section twenty-eight hundred seven-m of the public health law may receive a certificate that also includes the practice of molecular [diagnosis] testing including but not limited to genetic testing-molecular and molecular oncology, and restricted licensees employed at national cancer institute designated cancer centers may receive a certificate that includes the use of mass spectrometry or any tests and procedures acceptable to the commissioner

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11731-01-3

of health, in consultation with the commissioner, in the field of proteomics, provided that such certificate holders may practice in such additional areas only at such centers, teaching hospitals or other sites as may be designated by the commissioner.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to restricted clinical laboratory licenses

Purpose

To amend the molecular diagnosis restricted license related to consol- idating the license to streamline all aspects of molecular testing.

Summary of specific provisions

Section 1 of the bill amends section 8610 of the education law by amend- ing the molecular diagnosis restricted license.

Section 2 of the bill is the effective date.

Justification

In 2004, New York State passed the Clinical Laboratory Technology Prac- tice Act. Starting in 2006, pursuant to the Act, a person could not work in a clinical laboratory without an appropriate generalist license in the appropriate area. In 2008, legislation was passed to add restricted license categories for those areas where a generalist license was unnec- essary. One of the restricted licenses that was created was for molecu- lar diagnosis. The molecular diagnosis restricted license was created with very limited language reflecting the technology and need that existed at the time.

Since its original enactment, much has changed, and clinical laborato- ries and blood banks have indicated that there is a need to update the language related to the molecular diagnosis restricted license. In the last 15+ years since the restricted license was created, molecular test- ing has expanded far beyond the scope of the very limited areas for which the current restricted license was created.

The largest area of molecular testing is now infectious disease diagnos- tics, especially for highly communicable diseases, i.e., HIV, Hepatitis and COVID. The methods for molecular testing are similar for oncology, genetics and infectious disease and the technology has advanced to the point where much of the process is, or can be, automated. Staff trained in molecular testing can perform procedures in any of these diagnostic areas. Updating the restricted molecular diagnosis licenses to encompass all aspects of molecular testing would greatly enhance the pool of qual- ified staff and help avoid the staffing issue that we are anticipating with the end of EO 4 and the current restricted license limitations.

Legislative history

New bill.

Fiscal implications

None.

Effective date

Immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.